Looks Health Services Ltd

As of 13-Nov, Looks Health Services Ltd is currently priced at 5.04, reflecting a recent increase of 5.0%. Despite short-term gains, the stock has underperformed year-to-date and over the past three years, with a significant drop in investor participation indicating potential lack of confidence.

As of 12-Nov, Looks Health Services Ltd's stock price is at 4.80, down 44.7%, with erratic trading and below key moving averages, indicating a bearish trend. Year-to-date, it has declined 5.70%, significantly underperforming compared to the Sensex, which has risen 8.10%.

Looks Health will declare its results on 30 October 2025.

The top shareholders of Looks Health are Maxgainz Finserve Private Limited with 13.09%, Wave Capital Ltd and a foreign institutional investor each holding 6.93%, while individual investors collectively own 75.82% of the shares. There are no pledged promoter holdings or mutual fund investments in the company.

As of March 2022, the management team of Looks Health includes Pritesh Champalal Doshi (Chairperson & Managing Director), Kanchan Kaku (Company Secretary & Compliance Officer), Sejal Jain, and Devendra Sanghvi (both Independent Directors). They are responsible for the company's governance and oversight.

As of 16-Jul, Looks Health Services Ltd is experiencing a price increase to Rs. 8.68, with a notable 76.06% gain over the past week, significantly outperforming the benchmark Sensex. The stock's strong upward momentum is supported by rising investor participation and trading above key moving averages.

As of 15-Jul, Looks Health Services Ltd's stock price has risen to Rs. 8.31, marking a 4.92% increase and a new 52-week high. The stock has gained 68.56% over the last four days, significantly outperforming the Sensex, which has declined by 1.36% during the same period.

As of 14-Jul, Looks Health Services Ltd has seen a significant price increase to Rs. 7.92, up 20.0%, and has outperformed the Sensex with a one-week return of +66.74%. The stock's strong performance is attributed to company-specific factors, as it has maintained upward momentum and increased investor interest despite a declining broader market.

As of 11-Jul, Looks Health Services Ltd's stock price has risen to Rs. 6.60, marking a 20% increase and a new 52-week high. The stock has outperformed the Sensex significantly, with a weekly return of +35.25%, driven by strong investor participation and positive trading trends.

As of 10-Jul, Looks Health Services Ltd is experiencing a price increase to 5.50, reflecting an 11.56% rise and strong performance compared to its sector and the Sensex. The stock is trading above all major moving averages, indicating a positive trend, with significant investor participation and a year-to-date return of +8.06%.

As of 07-Jul, Looks Health Services Ltd's stock price is declining at 4.75, down 2.66%, and underperforming its sector. The stock is trading below all key moving averages, indicating a bearish trend, with significant drops in delivery volume and year-to-date performance.

As of 30-Jun, Looks Health Services Ltd's stock price is declining at 4.74, down 2.67% and underperforming its sector. The stock has fallen 24.16% over the past year, contrasting sharply with the Sensex's 5.79% gain, indicating weak investor interest and bearish sentiment.

As of 25-Jun, Looks Health Services Ltd's stock price is currently 4.70, up 1.73% today, but has declined 6.00% over the past week and 24.19% over the past year. Despite a recent increase in investor interest, the stock remains below key moving averages and underperforms compared to the benchmark Sensex.

As of June 6, 2025, Looks Health's trend is neutral with mixed indicators, showing a shift from mildly bearish to sideways, as weekly signals are mildly bullish while daily and monthly indicators suggest weakness and uncertainty.

As of June 6, 2025, Looks Health's trend is neutral with mixed indicators, showing a shift from mildly bearish to sideways, as weekly signals are mildly bullish while daily and monthly indicators suggest weakness and uncertainty.

As of April 25, 2023, Looks Health is considered overvalued and risky, with a low PE ratio of 5.25 and negative EV to EBITDA, despite a recent one-month stock return of 8.89%, which contrasts with its troubling one-year return of -10.09%.

Looks Health Services Ltd specializes in surgical and non-surgical cosmetic and aesthetic treatments. As of March 2025, the company reported net sales and net profit of 0 Cr, with a market cap of Rs 5 Cr.

Peers of Looks Health include Syngene Intl., Dr Lal Pathlabs, and Metropolis Health, among others. Management risk varies from excellent to below average, with Suven Life Sciences showing the highest 1-year return at 160.99%, while Looks Health's return is -14.13%.

Peers of Looks Health include Syngene Intl., Dr Lal Pathlabs, and Metropolis Health, among others. Management risk varies from excellent to below average, with Suven Life Sciences showing the highest 1-year return at 160.99%, while Looks Health's return is -14.13%.